Andere talen First Wave BioPharma, Inc.

Aandelen

FWBI

US33749P4081

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,73 ^USD	-9,60%		-3,87%	-35,00%

29/03	First Wave BioPharma, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
14/03	Sectorupdate: Gezondheidszorgaandelen trekken zich laat in de middag terug	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients	24/04
First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase	17/04
First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference	15/04
First Wave BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference	18/03
Sector Update: Health Care Stocks Retreating Late Afternoon	14/03
Sector Update: Health Care	14/03
First Wave BioPharma Shares Fall After Acquiring ImmunogenX	14/03
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Inflation Data	14/03
First Wave Biopharma, Inc. Announces Management Changes	14/03
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline	14/03
First Wave BioPharma, Inc. completed the acquisition of ImmunogenX, LLC for approximately $3 million.	13/03
First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference	05/03
First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering	04/03
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024	13/02
First Wave BioPharma to Present at the DealFlow MicroCap Conference	23/01
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico	17/01
Bull Run 2024: Biopharma Healthcare Stocks Surge, Gaining Momentum: DYAI, ABVC, FWBI, VTAK, NEXI	08/01
First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024	04/01
Top Premarket Gainers	03/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen First Wave BioPharma, Inc.

Aandelen

FWBI

US33749P4081

Andere talen

Filters